Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Melanoma

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Melanoma in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonchak, JG1
Eby, JM1
Willenborg, KA1
Chrobak, D1
Henning, SW1
Krzywiec, A1
Johnson, SL1
Le Poole, IC1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Melanoma

ArticleYear
Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.
    Archives of biochemistry and biophysics, 2014, Dec-01, Volume: 563

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Topical; Animals; Cell Differentiation; Cell

2014